Methods of treatment with CD80 extracellular domain polypeptides
US11789010B2 · kind B2 · utility
0Cited by
33References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2018 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Dec 23, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This application relates to use of CD80 (B7-1) extracellular domain (ECD) polypeptides and CD80-ECD fusion molecules and their use in methods of increasing the number of central memory T cells or for treatment for cancer or for use in cancer vaccine compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.